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Tumour metastasis is known clinically to have organ specificity. We hypothesised that integrins might be involved in determining the
organ specificity of tumour metastasis. Here, we report the results of spontaneous metastasis tested in nude mice that were
inoculated with Chinese hamster ovary (CHO) cells expressing integrin a5b1 at various levels. The growth of the primary tumour
inversely correlated with the a5 expression level on CHO cells, which is consistent with a previous report (Schreiner et al, 1991). The
rates of pulmonary, lymph node, and adrenal metastases that developed in nude mice were not related to changes of the a5
expression level on CHO cells. Kidney metastasis developed in 40% of nude mice inoculated with a5B2 cells (CHO cells
overexpressing a5) and in 20% of mice with CHO-K1 cells (CHO cells expressing native a5), whereas inoculation with CHO-B2 cells
(a5-defective mutants) and a5CHO cells with the highest expression of a5 did not lead to development of kidney metastasis.
Furthermore, a5CHO, which shows the slowest growth of these cell types, did not lead to primary tumours in nude mice. These
findings suggest that there is an appropriate level of a5 expression on tumour cells that leads to metastasis. Microscopic observations
revealed that micrometastasis in the kidney was formed in glomeruli. An adhesion assay using frozen sections of the kidney
demonstrated that a5B2 cells, but not CHO-B2 cells, effectively adhered to glomeruli. Kidney metastasis in vivo and the adhesion of
a5B2 to glomeruli shown ex vivo were significantly suppressed by the administration of GRGDS peptide. Finally, we conclude that the
interaction of a5b1 on tumour cells with fibronectin in kidney glomeruli is involved in kidney metastasis and that the tumour has
appropriate levels of integrins crucial for metastasis.
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INTRODUCTION
Clinically, it is well known that tumour metastasis has organ
specificity. Selectivity of the organs to which the tumour
metastasises is thought to be affected by interactions between
the tumour and molecules surrounding it (seed and soil theory)
(Paget, 1898), and the direction of blood flow (mechanical theory)
(Ewing, 1928). The process of tumour metastasis consists of
detachment of cells from the primary tumour, invasion of
extracellular matrix (ECM), intra- and extravasation, and growth
at the secondary site. Numerous data have been reported to
support the seed and soil theory as well as the mechanical theory
by means of these processes. In B16-F10 melanoma cells and
reticulum-cell sarcoma cells, organ specificity in their binding in
vitro and ex vivo reflected the organ specificity of their metastatic
distribution in vivo (Nicolson and Winkelhake, 1975; Netland and
Zetter, 1984). Tumour cells that metastasised selectively to a
specific organ showed intense adhesion to the endothelial cells
derived from this organ (Nicolson, 1988; Pauli and Lee, 1988).
Furthermore, an adhesion molecule designated Lu-ECAM-1 is
specifically expressed on endothelial cells derived from the lung
but not from other organs (Zhu et al, 1991). These findings suggest
that there might be specific molecules or proportions of proteins in
endothelial cells or ECM proteins in organs, that determine the
metastatic sites of tumour cells. Therefore, adhesion molecules
appear to be crucial for mediating the tumour–endothelial or
tumour–ECM interactions.
Integrins are transmembrane glycoproteins that consist of a and
b subunits and mediate cell–matrix and cell–cell adhesions
(Hynes, 1992). Varieties of a and b subunits produce ligand
selectivity to ECM (Albelda and Buck, 1990). To elucidate the role
of integrins in tumour progression leading to metastasis, integrin
expression levels have been compared in normal and tumour cells,
or in primary and secondary sites in cancer patients using
polymerase chain reaction (PCR), in situ hybridization, or
immunohistochemical techniques.
Changes of integrin expression or its localisation in transformed
cells appear to contribute either positively or negatively to the
transformed cell phenotype. For instance, a5b1 integrin is a key
molecule in the invasion at least of melanoma, osteosarcoma, and
glioblastoma cells, while aVb3 integrin also appears to be
associated with increased invasiveness (Ruoslahti, 1992). The
localisation of the fibronectin receptor on the cell surface is altered
in the malignant transformation of cultured human cells in
comparison with normal cells (Akiyama et al, 1990). In sarcoma
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svirus transformation of several rodent cell lines, a5b1 integrin
disappears from the cell surface, whereas a3b1 levels remain
constant (Heino, 1993). In melanoma, alterations of a2b1, a3b1,
and a6b1 integrins appear to be associated with malignancy (Chen
et al, 1991; Natali et al, 1991,1993; Moretti et al, 1993). In breast
cancer, a2b1, a5b1, or a6b4 integrins seem to be crucial for
malignant transformation (Pignatelli et al, 1991; Natali et al, 1992;
Zutter et al, 1993; Weaver et al, 1997). In pancreatic carcinoma cell
lines, expression of a2, a3, a6, b1, b4, and b5 integrins was
detected in adenocarcinomas and ampullary tumours, in the
normal pancreas, reduced levels of expression occur, or in the case
of some integrins there is no expression (Hall et al, 1991). These
strategies are beneficial in that integrin expression is directly
detected on tissues from patients or tumour cell lines.
In another strategy, tumour cells or mice with genetic changes of
integrin expression have been used for analysing the effects of
integrin on tumourigenesis and organ-preferential metastasis.
Rhabdomyosarcoma (RD) cells transfected with cDNA encoding
the a2 subunit enhanced metastasis in nude mice, demonstrating
the specific effect of a2b1 integrin on metastasis (Chan et al, 1991).
CHO cells transfected with a4 cDNA caused experimental bone
metastasis in nude mice, suggesting that bone metastasis was
induced by interactions between a4b1 on tumour cells and VCAM-
1 on stromal cells in the bone marrow (Matsuura et al, 1996). Here,
we constructed CHO transfectants expressing a5b1 at various
levels and examined metastatic sites in nude mice. In this study, we
especially focused on the relation between the change in a5b1
levels on tumour cells and rates of metastasis.
MATERIALS AND METHODS
Cells and culture conditions
CHO-K1 cells (ATCC, VA, USA) were used as parent cells in this
study. CHO-B2 cells are a5-defective mutants of CHO-K1 cells, that
exclusively express a5b1 integrin (Schreiner et al, 1989), and their
transfectants were designated as a5B2 and a5CHO cells, respec-
tively. A pBJ-1 vector carrying a5 cDNA driven by the SRa
promoter (Takebe et al, 1988) was transfected into CHO-K1 or
CHO-B2 cells. Cells expressing a5 were selected by flow cytometric
sorting and by resistance to geneticin (G418). a5B2F187A cells are
transfectants of CHO-B2 cells with mutant a5 cDNA containing an
alanine substitution of phenylalanine 187 (Irie et al, 1995). Cells
were maintained in Dulbecco’s modified Eagle’s medium (DMEM,
Nihonseiyaku, Tokyo, Japan), supplemented with 10% fetal bovine
serum (FBS, Dainippon Pharmaceutical Co., Ltd, Tokyo, Japan)
and 50Uml
 1 of penicillin plus 50mgml
 1 of streptomycin (Life
Technologies, Frederick, ML, USA) in 10% CO2.
Flow cytometric analysis
Cells in DMEM supplemented with 1% FBS and 0.03% sodium
azide were incubated with a monoclonal antibody against human/
hamster a5 (KH72) for 30min at 41C. After washing with DMEM as
described above, the cells were incubated with FITC-conjugated
mouse IgG (DAKO, Copenhagen, Denmark) for 30min at 41C.
After washing, cells were resuspended with the same DMEM and
analysed by FACS Calibur (BD Biosciences, CA, USA).
Spontaneous metastasis model in nude mice
Nude mice (BALB/cAnNCrj-nu/nu, 4 weeks, female) were sub-
cutaneously injected with 1 10
6 cells of parental, mutant, or
transfectant CHO cells. Subcutaneous tumours were measured
with a dial-caliper twice a week and volumes were determined
using the formula width
2 length 0.52. Each volume value
indicates the mean7standard errors (s.e.). Primary tumours were
removed surgically at a size of 2500–3500mm
3 to prevent mice
from dying. The mice were killed and metastatic sites were
examined 7–8 weeks after inoculation. To investigate whether
kidney metastasis was caused by adhesion of a5b1 on tumour cells
to fibronectin, the effects of intravenous tail vein injection of
GRGDS or GRGES peptide (20mgkg
 1 in 50ml each) in PBS had
been tested every other day starting from day 5 for 7 weeks.
Histological analysis
Kidney and lung were excised and fixed with formalin. Horizontal
sections (6mm thick) were prepared from the centre of the tumour
in paraffin-embedded tissue. The sections were stained with
haematoxylin–eosin and metastatic sites were examined by
microscopy.
Adhesion assay
A total of 96-well plastic plates were coated with 10mgml
 1 of
fibronectin in phosphate-buffered saline (PBS) for 2h at 371C and
then treated with 3% bovine serum albumin (BSA) for 1h at 371C,
or were coated with only BSA for negative control. The cells
(5 10
4cellswell
 1) in serum-free DMEM containing 0.1% BSA
were added and incubated for 1h at 371C. After removal of the
medium, a 0.04% crystal violet solution was added and incubation
was conducted for 10min at room temperature. The wells were
washed three times with PBS and 20ml of Triton X-100 was added
for permeabilisation. After addition of distilled water to 100ml, the
optical density was measured at 550nm. The value indicates the
mean7s.e. for triplicate data representing three independent
experiments.
Spreading assay
Cells (5 10
3cellswell
 1) in serum-free DMEM containing 0.1%
BSA were added to plates coated with 10mgml
 1 of fibronectin (96
wells), and incubated for 3h at 371C. The cells were photographed
on slide film under microscopy and the images on the film were
analysed by NIH Image (National Institutes of Health, Bethesda,
MD, USA). The spreading area of each cell type was calculated. The
value indicates the mean7s.e. for 20 cells randomly sampled.
Migration assay
Cell migration to soluble fibronectin was assessed by multiwell
Boyden chambers (Neuro Probe, Gaithersburg, MD, USA).
Polycarbonate filters (pore size of 8mm) were coated with
10mgml
 1 of fibronectin (Asahi Techno Glass, Tokyo, Japan) for
30min at room temperature and air-dried. The lower part of the
chamber was filled with 10mgml
 1 of fibronectin in serum-free
DMEM containing 0.1% BSA or with a medium containing BSA
only. Cells (2 10
4well
 1)i n5 0ml of DMEM containing 0.1% BSA
were applied to the upper part of the chamber and incubated for
3h under 5% CO2 at 371C. The upper side of the filter was scraped
with a cotton swab. The filters were fixed with formalin and stained
with haematoxylin. The number of cells on the lower side was
counted. The value indicates the mean7s.e. for triplicate data
representing three independent experiments.
Adhesion assay on the tissue
An adhesion assay on kidney sections was performed according to
the Stamper–Woodruff assay (Stamper and Woodruff, 1976). The
kidneys were removed from nude mice and immediately frozen by
liquid N2. Horizontal sections (10mm thick) used for one assay
were prepared from the same tissues and mounted on glass slides.
Mock-transfected CHO-B2 and a5B2 cells (1 10
6cells in 1ml of
DMEM supplemented with 10% FBS) were fluorescence-labelled by
3mlo f1 m M BCECF-AM DMSO solution (Wako Pure Chemical
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sIndustries, Ltd, Hokkaido, Japan) and incubated for 30min at
room temperature. Excess BCECF was washed off with PBS and the
cells were resuspended in 10mM HEPES (pH 7.4). Cells (1 10
5 in
0.1ml of HEPES) were preincubated with GRGDS or GRGES
peptide (200mgml
 1) for 30min at 41C and applied onto tissue
sections marked by a wax pen and incubated for 30min at room
temperature with moderate rotation (60r.p.m.). Unbound cells
were washed away with PBS and the sections were fixed with 3%
glutaraldehyde in PBS. Cell nuclei were stained with propidium
iodide. The sections were air-dried and the number of cells
adhering to glomeruli were counted by confocal laser microscopy
(LSM-GB200, OLYMPUS, Tokyo, Japan). The value indicates the
mean7s.e. for 20 glomeruli randomly selected and representing
three independent experiments.
Statistical analysis
The w
2 test was used to determine the significance of the in vivo
metastasis experiments. The statistical analysis of the adhesion
assay was performed by Kruskal–Wallis ANOVA. A Po0.05 value
was regarded as statistically significant.
RESULTS
Expression level of a5 subunit on each CHO cell
To confirm the expression level of the a5 subunit on each CHO cell
type, we carried out a flow cytometric analysis (Figure 1). Since the
counterpart of the a5 subunit is only the b1 subunit, the expression
level of the a5 subunit indicates that of a5b1 integrin. a5CHO cells
showed the highest level of a5b1 integrin. a5B2 cells had a higher
expression of a5b1 than CHO-K1 (mock) cells with the endogen-
ous level. No a5 expression was observed in CHO-B2 (mock) cells,
which are a5-defective mutants. a5 expression on a5B2F187A cells
was almost the same level as a5B2 cells.
Growth of primary tumour in vivo and cell
proliferation in vitro
After the cells were inoculated subcutaneously into nude mice, the
size of the tumour was measured twice a week (Figure 2). The
growth of the primary tumour was inversely correlated with a5
expression levels on CHO cells as previously reported (Schreiner
et al, 1991). a5CHO cells expressing a5b1 at the highest level did
not produce a primary tumour. In a cell-proliferation assay, CHO
cells with increased a5 expression on fibronectin showed reduced
cell proliferation as well as reduced cell growth in vivo (data not
shown).
Metastatic sites and rate of metastasis observed
in nude mice subcutaneously inoculated with
each CHO cell type
To identify the role of a5 expression on CHO cells in metastasis, we
examined the organs with spontaneous metastasis in nude mice
(Table 1). Lung metastasis was frequently seen in nude mice
inoculated with parent CHO-K1 (mock, 100%), a5-defective
mutants (CHO-B2, mock, 90.4%), or a5 transfectants (a5B2,
89.4%). This means that lung metastasis at least in this study
appears to be primarily because of physical trapping of CHO cells
by microvessels rather than interactions between a5b1 on CHO
cells and fibronectin. Metastases in adrenal glands and lymph
nodes were observed in nude mice at a lower level of 0–30%. These
metastases also seem to have no relation to a change of a5
expressions on CHO cells. On the other hand, the rate of kidney
metastasis changed in association with the expression levels of a5
on CHO cells. Both CHO-B2 cells with no a5 expression and
a5B2F187A cells expressing mutated a5 did not give rise to kidney
metastasis in nude mice. CHO-K1 cells with a native level of a5
produced kidney metastasis in nude mice at levels of 22.7–27.7%.
a5B2 cells with a higher level of a5 than CHO-K1 cells caused
kidney metastasis at a higher level of 30–50%. a5CHO cells with
the highest level of a5 did not give rise to kidney metastasis in
nude mice, since a5CHO cells could not produce a primary tumour
because of their very slow growth. These findings indicate the
possibility that kidney metastasis might be particularly caused by
interactions between a5b1 on tumour cells and fibronectin in the
kidney. Furthermore, kidney metastasis induced by a5B2 was
significantly inhibited by intravenous administration of GRGDS
peptide (10%) when compared to GRGES peptide (42.1%)
(Po0.05), whereas the administration of GRGDS peptide did not
affect the metastatic rate of any other organs investigated. This
suggests that the adhesion of a5B2 cells to fibronectin via integrin
a5b1 might have a crucial role in the induction of kidney metastasis.
Macroscopic and microscopic findings of kidney
metastasis in nude mice
The macroscopic appearance of kidney metastasis is shown in
Figure 3A. The arrowhead indicates a metastatic site formed in the
right kidney of a nude mouse inoculated with a5B2 cells, this
mouse also has an adrenal metastasis. To identify where a5B2 cells
were first trapped in the kidney, we observed micrometastatic sites
in kidney sections stained with haematoxylin–eosin. In all nude
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Figure 1 Flow cytometric analysis of a5 expression on CHO. Human
and Chinese hamster a5 was detected by mAb KH72 on each CHO cell.
CHO-K1 cells expressed a5 at the endogenous level and CHO-B2 cells,
a5-defective mutant, did not express a5. Among three transfectants of
a5B2, a5B2F187A, and a5CHO cells, a5CHO showed the highest
expression of a5.
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Figure 2 Growth of primary tumour in nude mice. Each growth curve
shows primary tumour volume of nude mice inoculated subcutaneously
with CHO cells (10
6cellsmouse
 1). The growth of tumour volume was
reversely correlated with a5 expression level on CHO cells. In nude mice
inoculated with a5CHO cells, no primary tumour was observed. Each value
shows the mean7s.e. (n¼8).
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smice with kidney metastasis, metastatic sites were formed in the
kidney cortex region (Figure 3B, arrowhead). Furthermore, all
micrometastases were shown in the kidney glomeruli (Figure 3C,
arrowhead). These findings demonstrate that kidney metastasis
develops first by the adhesion of a5b1 on CHO cells to fibronectin in
the kidney glomerulus.
Table 1 Metastasis formation of CHO and their transfectants inoculated subcutaneously into nude mice
Cells and treatments No. of mice analysed % Lung % Kidney % Adrenal % Lymph node
CHO-B2 (mock) 21 90.4 0 19 9.5
CHO-K1 (mock) 22 100 22.7* 27.2 13.6
a5B2 19 89.4 47.3*** 21 10.5
a5CHO 10 FF F F
a5B2F187A 13 100 0 15.3 23
CHO-B2 23 91.3 0 21.7 8.6
CHO-K1 18 88.8 27.7* 27.7 11.1
a5B2 clone 1 10 100 30* 20 10
a5B2 clone2 10 90 50** 30 0
a5B2+GRGDS 20 90 10* 20 10
a5B2+GRGES 19 100 42.1 21 10.5
Mice were killed 7–8 weeks after inoculation. In metastasis inhibition experiment using GRGDS or GRGES peptide, 20mgkg
 1
peptide was administered to mice every other day since 5 days after inoculatin. Since a5CHO did not develop primary tumour,
metastasis sites were not formed. The w
2 analysis shows that there is a significant difference compared with the metastasis rate
CHO-B2 (*Po0.05, **Po0.01, ***Po0.001). The values of a5B2+GRGDS treatments were assessed by the w
2 analysis
compared with that of a5B2+GRGES treatments.
Figure 3 Macroscopic and microscopic findings of the kidney metastasis shown in a nude mouse inoculated with a5B2 cells. (A) a nude mouse with the
kidney metastasis caused by a5B2 inoculation. The mouse was in supine position and intraperitoneal examination was performed after the laparotomy. An
arrowhead shows the metastasis site in the right kidney; this mouse also has the adrenal metastasis. (B) Haematoxylin and eosin(HE)-stained section of
tumour (arrowhead) in the kidney. All kidney metastases were found in the kidney cortex region. (C) HE-stained section of micrometastasis (arrowhead)
developed in the kidney glomerulus. The lower glomerulus formed a micrometastasis site caused by a5B2 whereas the upper glomerulus was normal.
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sAdhesion and migration of CHO cells to fibronectin in
vitro
To estimate whether it is cell adhesion or migration that is
supposed to be crucial for kidney metastasis formation, the
behaviour of each CHO cell type relative to fibronectin was
analysed in vitro. In the adhesion assay, CHO cells with greater a5
expression effectively adhered to fibronectin, whereas a5B2F187A
cells with the alanine mutation and CHO-B2 cells did not adhere to
fibronectin (Figure 4A). Likewise, CHO cells showed an increase in
cell spreading that correlated with the overexpression of a5
(Figure 4B). Since tumour cells in intravasation penetrate into
blood vessels containing abundant soluble fibronectin
(300mgml
 1) in serum (Mosesson and Umfleet, 1970), the cell
migration of each CHO cell type was estimated by a cell migration
assay. In contrast to the results of adhesion and spreading assay, of
all the CHO cells investigated, CHO-K1 cells with the native level of
a5 migrated most effectively to fibronectin (Figure 4C). These data
are consistent with the theory that cell migration is controlled by
dynamic interactions between cell receptors and substratum
ligands in a manner representing events at the front and rear of
the migrating cells (Palecek et al, 1996, 1997; Regen and Horwitz,
1992). The rate of kidney metastasis appears to shift in parallel
with the adhesion of CHO cells to fibronectin, except for a5CHO
cells that do not develop a primary site.
Adhesion of a5B2 cells to kidney tissue sections and
inhibition by GRGDS peptide
To identify whether kidney metastasis is primarily caused by
interactions between a5b1 on CHO cells and fibronectin in
glomeruli, we performed an adhesion assay with frozen sections.
In this assay, the artificial binding of CHO cells to cortex regions
such as uriniferous tubules other than glomeruli was seen because
of adhesion of tumour cells in the absence of extravasation.
Therefore, adhesion of a5B2 cells to glomeruli was estimated by
focusing on the binding of cells (yellow spots) to glomeruli
(accumulating red spots) (Figure 5A). The number of cells on
glomeruli for the different CHO cell types investigated is shown in
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Figure 4 Adhesion and migration of CHO cells to fibronectin. (A)
Adhesion assay demonstrating that adhesion activities to fibronectin in each
CHO cell depend on a5 expression level. Cells (5 10
4well
 1) in serum-
free DMEM containing 0.1% BSA were plated on coated
fibronectin(10mgml
 1) and incubated for 1h at 371C. Cells binding to
fibronectin that were stained with crystal violet were assessed by measuring
optical density at 550nm. Results are expressed as the percentage
compared with CHO-K1 cells (mock). Each value is the mean7s.e. of
triplicate data representative for three independent experiments. (B)
Spreading assay quantifying increased binding area in cell adhesion to
fibronectin compared with cell spreading on BSA. Each cell in serum-free
DMEM containing 0.1% BSA was plated on coated fibronectin (10mgml
 1)
and incubated for 3h at 371C. Each value is the mean7s.e. of 20 cells
randomly selected. The same results were obtained in two independent
experiments. (C) Boyden chamber assay evaluating migration acitivity of
each CHO to soluble fibronectin. A chamber with 10
5cellswell
 1 in the
upper chamber and 10mgml
 1 fibronectin in the lower chamber was
incubated for 3h at 371C in 10% CO2. The number of cells migrating to the
lower side of the filter was assessed as a percentage compared with CHO-
K1 cells (mock). Each value is the mean7s.e. of triplicate data,
representative for three independent experiments.
Figure 5 Effects of GRGDS peptide on adhesion of a5B2 to the
glomerulus in the kidney section. (A) Laser microscopic appearance of
adhesion assay on the kidney section. 10
5cells/section were incubated for
30min with gentle rotation. a, CHO-B2 cells (yellow spots), a5-defective
mutant, slightly adhere to the glomerulus (red spots). b, a5B2 cells which
were a5 transfectants effectively adhered to the glomerulus. c, Adhesion of
a5B2 cells to the glomerulus was not changed by administration of
200mgml
 1 GRGES peptide. d, Adhesion of a5B2 cells to the glomerulus
was inhibited by administration of 200mgml
 1 GRGDS peptide. (B) Cell
number per glomerulus (n¼20). Note that adhesion of a5B2 cells with
GRGDS treatment to the glomerulus was significantly inhibited as
compared with GRGES treatment (*Po0.0001).
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sFigure 5B. a5B2 cells adhered well to glomeruli whereas CHO-B2
cells with no a5b1 hardly adhered at all. The adhesion of a5B2 cells
to glomeruli was significantly inhibited by the administration of
GRGDS peptide, but not by GRGES peptide, when compared with
the adhesion of a5B2 cells with no treatment (Po0.0001). These
findings demonstrate that micrometastasis in glomeruli in mice
may occur through interactions between a5b1 on tumour cells and
fibronectin in the glomeruli.
DISCUSSION
In this study, we constructed CHO cell types with various levels of
integrin a5b1 to investigate the relation between a5b1 expression
on tumour cells and organ-preferential metastasis. Furthermore,
we focused on alterations of the metastatic rate associated with
different levels of a5b1. Previous studies have reported that the
expression of a5b1 on tumour cells is inversely correlated with
tumourigenicity (Giancotti and Ruoslahti, 1990; Schreiner et al,
1991). Moreover, the loss of fibronectin or a5b1 on tumour cells
had no effect on tumourigenesis or metastasis in chimeric mice
containing many a5-null cells (Taverna et al, 1998). However, it
remains unknown how metastatic rates change in the case of
abundant a5 expression on tumour cells. Furthermore, since the
expression of a5b1 on tumour cells has been thought to make the
phenotype of tumour cells normal, a5b1 expression might play a
minor role in the tumour metastatic process. Here, we report that
the expression of a5b1 on tumour cells is involved in the
development of kidney metastasis. The inhibition of kidney
metastasis in vivo and the adhesion of a5B2 cells to kidney
sections ex vivo by administration of GRGDS peptide, both suggest
that kidney metastasis might be induced by adhesion of tumour
cells via a5b1 to fibronectin in the kidney glomerulus. Since RGD
peptide is also found in laminin, collagen, and vitronectin, in
addition to fibronectin, GRGDS peptide does not necessarily
specifically inhibit the adhesion of a5b1 to fibronectin. CHO cells,
however, predominantly express a5b1, and no ligand molecule
other than fibronectin has been found in previous reports.
Therefore, GRGDS peptide specifically inhibits the adhesion
between a5b1 on CHO cells and fibronectin. Since a quarter of
the total blood volume effused from the heart flows into the kidney
(Churg and Sobin, 1982), many tumour cells seem to interact with
capillaries in the glomeruli, suggesting the possibility that kidney
metastasis could develop from tumour cells physically trapped by
vessels. In this study, however, CHO-B2 cells with no a5 did not
induce kidney metastasis in mice. Therefore, micrometastasis in
glomeruli appears to be brought about primarily by the adhesive
interaction of a5b1 on tumour cells with fibronectin in glomeruli.
In a spontaneous metastasis test, both CHO-B2 (mock) cells
with no a5b1 and a5CHO cells with the highest level of a5b1 did
not give rise to kidney metastasis in nude mice, whereas kidney
metastases were seen in about 40% and 25% of mice inoculated
with a5B2 and CHO-K1 cells, respectively (Table 1). This
demonstrates that tumour cells have integrin expression levels
appropriate for developing metastatic sites. At a primary site,
tumour cells with lower levels of a5b1 show rapid growth adequate
for developing metastatic sites. However, once tumour cells
intravasate, cells with higher levels of a5b1 appear to adhere
easily to fibronectin to form metastatic sites.
How do tumour cells interact with fibronectin in kidney
glomeruli? Since basement membranes of glomerular vessels
contain a small amount of fibronectin compared with collagen
and laminin (Yurchenco and Schittny, 1990) as well as general
basement membranes, CHO cells with a5b1 might have difficulty
in adhering directly to fibronectin in basement membranes of
glomeruli during metastasis. The glomerular capillary is known to
have a characteristic structure in relation to its surrounding
basement membranes. In glomeruli, several blood vessels are
surrounded by a basement membrane along the lateral side of
endothelial cells, whereas a common blood vessel is covered with a
basement membrane. Furthermore, at the medial side of the
glomerular capillary, endothelial cells and mesangial cells without
basement membranes are present (Ramzi et al, 1999). Since
mesangial cells surrounded by glomerular blood vessels are known
to produce ECM proteins containing abundant fibronectin
(Couchman et al, 1994), tumour cells seem to interact easily with
fibronectin by invading only the endothelial cells but not the
basement membranes. On the other hand, lung, adrenal, and
lymph node metastatic rates appear to be independent of a5
expression level on CHO cells. In these organs, integrins other than
a5b1 or other molecules on tumour cells might be involved in the
development of metastatic sites in addition to physical trapping of
cells by microvessels.
In conclusion, we demonstrated that a5 expression levels on
tumour cells might affect kidney metastasis rates. Therefore, the
inhibition of kidney metastasis by targeting cell adhesion might be
essential for metastasis therapy.
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